Frank C. Barone

Frank C. Barone, PhD, is a Professor of Neurology and Physiology & Pharmacology at SUNY Downstate Medical Center, and Director of Cerebrovascular Basic Research and Medical Student Research. He holds dual affiliations in Neurology and Physiology & Pharmacology departments. His career spans academia and industry, including 25 years at GlaxoSmithKline (GSK) as a Biology Leader, followed by consulting for pharmaceutical companies like Wyeth-Pfizer. He founded the Albert Research Institute for White Matter and Cognition to advance dementia research collaboration.

Dr. Barone’s education includes a PhD in Biopsychology-Neuroscience from Syracuse University (1973–1982), where he also served as a Research Assistant Professor. His research focuses on cerebrovascular and neurodegenerative diseases, particularly Alzheimer’s and mixed dementia. Key interests include biomarkers (e.g., exosomes) for diagnosis, prognosis, and monitoring cognitive recovery. He also promotes medical student research training and clinical-translational studies on brain-circulating interactions.

His publications (2008–1998) emphasize stroke mechanisms, neuroprotection, and neuroinflammation, using animal models and genomic approaches. While no explicit grants or awards are noted, his leadership roles and prolific research output highlight his contributions to stroke and dementia science.

Labs/Teams: Founder and President of the Albert Research Institute, fostering interdisciplinary dementia research networks.